Cohu Inc reported disappointing fourth-quarter adjusted EPS results that fell short of expectations, potentially leading investors to reevaluate the company's growth trajectory. The earnings miss highlights operational challenges that could impact future earnings and investor sentiment adversely.
U.S. stocks fell, Dow down over 150 points. Cohu shares dropped 12.7% after convertible senior notes offering. Freeport-McMoRan declined due to lower sales guidance and tragic incident. Harmony Biosciences faced losses after failed clinical trial. Other stocks also saw significant declines in today's session.